CN Stock MarketDetailed Quotes

600613 Shanghai Shenqi Pharmaceutical Investment Management

Watchlist
  • 5.69
  • +0.22+4.02%
Market Closed Jun 7 15:00 CST
3.04BMarket Cap53.18P/E (TTM)

Shanghai Shenqi Pharmaceutical Investment Management Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-1.42%574.53M
-2.00%2.34B
-0.13%1.71B
0.29%1.21B
-0.93%582.8M
3.72%2.39B
0.57%1.71B
4.03%1.2B
6.41%588.24M
26.61%2.3B
Operating revenue
-1.42%574.53M
-2.00%2.34B
-0.13%1.71B
0.29%1.21B
-0.93%582.8M
3.72%2.39B
0.57%1.71B
4.03%1.2B
6.41%588.24M
26.61%2.3B
Other operating revenue
----
212.18%677.34K
----
-47.51%2.54M
----
-92.58%216.97K
----
130.61%4.83M
----
675.53%2.92M
Total operating cost
-1.35%543.62M
-2.75%2.25B
-0.06%1.63B
-0.72%1.15B
-1.32%551.05M
3.40%2.31B
0.01%1.63B
5.93%1.16B
6.79%558.44M
22.76%2.23B
Operating cost
8.18%291.96M
4.19%1.17B
8.49%825.03M
1.68%568.51M
1.43%269.89M
22.72%1.12B
10.20%760.5M
15.28%559.11M
12.57%266.08M
24.68%916.7M
Operating tax surcharges
-5.25%9.99M
-1.93%29.07M
-5.02%22.73M
14.06%16.49M
17.77%10.54M
8.88%29.64M
14.09%23.93M
3.24%14.46M
16.97%8.95M
21.41%27.23M
Operating expense
-6.80%212.44M
-9.30%909.41M
-7.62%677.56M
-4.03%495.26M
-10.65%227.95M
-11.63%1B
-10.35%733.45M
-2.50%516.04M
2.92%255.11M
24.27%1.13B
Administration expense
-6.28%18.62M
-1.80%92.53M
-3.28%62.22M
-4.09%41.1M
2.80%19.86M
-3.07%94.23M
-5.82%64.33M
-5.00%42.85M
-6.91%19.32M
-2.99%97.22M
Financial expense
-54.74%1.65M
-10.96%10.92M
-13.11%7.99M
-8.17%6.01M
25.33%3.64M
75.16%12.27M
307.48%9.2M
326.77%6.55M
302.95%2.9M
20.45%7M
-Interest expense (Financial expense)
-40.85%3.02M
-14.98%14.76M
-14.14%10.9M
-14.41%7.72M
-4.95%5.1M
108.31%17.37M
277.67%12.7M
342.91%9.02M
425.22%5.37M
68.93%8.34M
-Interest Income (Financial expense)
-14.37%-1.46M
19.48%-5.16M
17.11%-3.62M
22.96%-2.37M
38.31%-1.28M
-166.98%-6.41M
-129.92%-4.37M
-193.99%-3.07M
-8,076.76%-2.07M
-202.20%-2.4M
Research and development
-53.24%8.96M
-29.76%32.3M
-13.82%31.49M
18.14%21.26M
215.75%19.16M
-9.73%45.99M
30.39%36.54M
4.34%17.99M
-36.43%6.07M
19.06%50.95M
Credit Impairment Loss
--90.36K
2,071.77%47.69M
-256.40%-4.38M
-1,493.15%-4.43M
----
-109.84%-2.42M
96.08%-1.23M
83.34%-278.16K
379.98%85.84K
114.04%24.58M
Asset Impairment Loss
----
-361.85%-72.41M
69.97%-2.09M
-3,641.37%-2.09M
----
44.27%-15.68M
-465.93%-6.97M
112.65%59.12K
----
83.42%-28.13M
Other net revenue
-16.12%837.76K
9.16%-11.8M
104.87%461.62K
-236.36%-3.85M
4.38%998.77K
-140.62%-12.99M
-366.89%-9.48M
52.58%2.82M
-45.06%956.9K
109.48%31.98M
Fair value change income
-112.53%-7.88K
--897.68K
--571.75K
--25.79K
--62.89K
----
----
----
----
----
Invest income
----
-54.10%810.17K
----
----
----
-93.72%1.77M
-99.01%300K
-91.21%300K
-81.94%300K
2,307.53%28.11M
-Including: Investment income associates
----
433.25%347.03K
----
----
----
-89.57%65.08K
----
----
----
1,247.55%623.69K
Asset deal income
2,940.58%151.92K
105.19%268.66K
100.62%31.85K
-825.49%-74.55K
--5K
-155,514.26%-5.17M
-34,825.21%-5.1M
--10.28K
----
-170.93%-3.32K
Other revenue
-35.18%603.36K
28.60%10.95M
80.18%6.33M
-0.04%2.73M
63.01%930.89K
14.57%8.51M
-40.30%3.51M
375.94%2.73M
371.10%571.06K
22.64%7.43M
Operating profit
-3.06%31.75M
25.80%82.84M
11.39%83.98M
10.71%53.2M
6.45%32.75M
-34.97%65.85M
-4.40%75.39M
-26.44%48.06M
-2.69%30.76M
129.95%101.27M
Add:Non operating Income
-79.45%28.45K
-0.84%931.93K
-35.75%796.06K
99.51%643.73K
6.10%138.46K
46.44%939.87K
100.91%1.24M
3.43%322.66K
-36.80%130.5K
-55.91%641.8K
Less:Non operating expense
3,209.69%389.84K
-89.81%363.16K
21.36%649.33K
-64.68%175.19K
-83.86%11.78K
54.29%3.56M
-74.70%535.05K
-75.50%496.06K
-59.41%72.97K
-36.39%2.31M
Total profit
-4.53%31.38M
31.92%83.41M
10.55%84.12M
12.09%53.67M
6.66%32.87M
-36.52%63.23M
-1.64%76.09M
-24.73%47.88M
-2.59%30.82M
129.27%99.6M
Less:Income tax cost
-34.24%6.26M
68.40%25.15M
-2.54%18.67M
26.74%19.16M
32.34%9.52M
-52.79%14.93M
-18.32%19.16M
-22.81%15.12M
-21.22%7.2M
139.76%31.64M
Net profit
7.59%25.12M
20.63%58.26M
14.96%65.45M
5.33%34.51M
-1.16%23.35M
-28.94%48.29M
5.61%56.93M
-25.59%32.76M
4.97%23.62M
FLtoP67.96M
Net profit from continuing operation
7.59%25.12M
20.63%58.26M
14.96%65.45M
5.33%34.51M
-1.16%23.35M
-28.94%48.29M
5.61%56.93M
-25.59%32.76M
4.97%23.62M
--67.96M
Less:Minority Profit
367.98%1.18M
595.39%1.26M
-133.53%-498.72K
-128.77%-227.1K
-375.76%-439.74K
84.70%-254.05K
68.47%1.49M
329.06%789.35K
-77.45%159.47K
86.47%-1.66M
Net profit of parent company owners
0.65%23.94M
17.41%57M
18.94%65.95M
8.64%34.74M
1.39%23.79M
-30.27%48.55M
4.57%55.45M
-27.94%31.97M
7.64%23.47M
120.41%69.62M
Earning per share
Basic earning per share
0.00%0.04
22.22%0.11
20.00%0.12
0.00%0.06
0.00%0.04
-30.77%0.09
0.00%0.1
-25.00%0.06
0.00%0.04
120.31%0.13
Diluted earning per share
0.00%0.04
22.22%0.11
20.00%0.12
0.00%0.06
0.00%0.04
-30.77%0.09
0.00%0.1
-25.00%0.06
0.00%0.04
120.31%0.13
Other composite income
-88.74%223.7K
140.59%4.81M
127.98%3.67M
177.52%6.69M
125.85%1.99M
-198.47%-11.86M
-672.58%-13.11M
-38.43%-8.63M
-29.88%-7.69M
-343.13%-3.97M
Other composite income of parent company owners
-88.74%223.7K
140.59%4.81M
127.98%3.67M
177.52%6.69M
125.85%1.99M
-402.81%-11.86M
-672.58%-13.11M
-38.43%-8.63M
-29.88%-7.69M
-244.32%-2.36M
Other composite income of minority owners
----
----
----
----
----
----
----
----
----
---1.62M
Total composite income
0.03%25.35M
73.12%63.07M
57.74%69.12M
70.70%41.2M
59.00%25.34M
-43.06%36.43M
-22.02%43.82M
-36.14%24.13M
-3.92%15.94M
118.19%63.99M
Total composite income of parent company owners
-6.24%24.17M
68.49%61.81M
64.45%69.62M
77.45%41.42M
63.39%25.78M
-45.46%36.69M
-23.47%42.33M
-38.79%23.34M
-0.64%15.78M
119.81%67.26M
Total composite income of minority owners
367.98%1.18M
595.39%1.26M
-133.53%-498.72K
-128.77%-227.1K
-375.76%-439.74K
92.24%-254.05K
68.47%1.49M
329.06%789.35K
-77.45%159.47K
73.31%-3.28M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -1.42%574.53M-2.00%2.34B-0.13%1.71B0.29%1.21B-0.93%582.8M3.72%2.39B0.57%1.71B4.03%1.2B6.41%588.24M26.61%2.3B
Operating revenue -1.42%574.53M-2.00%2.34B-0.13%1.71B0.29%1.21B-0.93%582.8M3.72%2.39B0.57%1.71B4.03%1.2B6.41%588.24M26.61%2.3B
Other operating revenue ----212.18%677.34K-----47.51%2.54M-----92.58%216.97K----130.61%4.83M----675.53%2.92M
Total operating cost -1.35%543.62M-2.75%2.25B-0.06%1.63B-0.72%1.15B-1.32%551.05M3.40%2.31B0.01%1.63B5.93%1.16B6.79%558.44M22.76%2.23B
Operating cost 8.18%291.96M4.19%1.17B8.49%825.03M1.68%568.51M1.43%269.89M22.72%1.12B10.20%760.5M15.28%559.11M12.57%266.08M24.68%916.7M
Operating tax surcharges -5.25%9.99M-1.93%29.07M-5.02%22.73M14.06%16.49M17.77%10.54M8.88%29.64M14.09%23.93M3.24%14.46M16.97%8.95M21.41%27.23M
Operating expense -6.80%212.44M-9.30%909.41M-7.62%677.56M-4.03%495.26M-10.65%227.95M-11.63%1B-10.35%733.45M-2.50%516.04M2.92%255.11M24.27%1.13B
Administration expense -6.28%18.62M-1.80%92.53M-3.28%62.22M-4.09%41.1M2.80%19.86M-3.07%94.23M-5.82%64.33M-5.00%42.85M-6.91%19.32M-2.99%97.22M
Financial expense -54.74%1.65M-10.96%10.92M-13.11%7.99M-8.17%6.01M25.33%3.64M75.16%12.27M307.48%9.2M326.77%6.55M302.95%2.9M20.45%7M
-Interest expense (Financial expense) -40.85%3.02M-14.98%14.76M-14.14%10.9M-14.41%7.72M-4.95%5.1M108.31%17.37M277.67%12.7M342.91%9.02M425.22%5.37M68.93%8.34M
-Interest Income (Financial expense) -14.37%-1.46M19.48%-5.16M17.11%-3.62M22.96%-2.37M38.31%-1.28M-166.98%-6.41M-129.92%-4.37M-193.99%-3.07M-8,076.76%-2.07M-202.20%-2.4M
Research and development -53.24%8.96M-29.76%32.3M-13.82%31.49M18.14%21.26M215.75%19.16M-9.73%45.99M30.39%36.54M4.34%17.99M-36.43%6.07M19.06%50.95M
Credit Impairment Loss --90.36K2,071.77%47.69M-256.40%-4.38M-1,493.15%-4.43M-----109.84%-2.42M96.08%-1.23M83.34%-278.16K379.98%85.84K114.04%24.58M
Asset Impairment Loss -----361.85%-72.41M69.97%-2.09M-3,641.37%-2.09M----44.27%-15.68M-465.93%-6.97M112.65%59.12K----83.42%-28.13M
Other net revenue -16.12%837.76K9.16%-11.8M104.87%461.62K-236.36%-3.85M4.38%998.77K-140.62%-12.99M-366.89%-9.48M52.58%2.82M-45.06%956.9K109.48%31.98M
Fair value change income -112.53%-7.88K--897.68K--571.75K--25.79K--62.89K--------------------
Invest income -----54.10%810.17K-------------93.72%1.77M-99.01%300K-91.21%300K-81.94%300K2,307.53%28.11M
-Including: Investment income associates ----433.25%347.03K-------------89.57%65.08K------------1,247.55%623.69K
Asset deal income 2,940.58%151.92K105.19%268.66K100.62%31.85K-825.49%-74.55K--5K-155,514.26%-5.17M-34,825.21%-5.1M--10.28K-----170.93%-3.32K
Other revenue -35.18%603.36K28.60%10.95M80.18%6.33M-0.04%2.73M63.01%930.89K14.57%8.51M-40.30%3.51M375.94%2.73M371.10%571.06K22.64%7.43M
Operating profit -3.06%31.75M25.80%82.84M11.39%83.98M10.71%53.2M6.45%32.75M-34.97%65.85M-4.40%75.39M-26.44%48.06M-2.69%30.76M129.95%101.27M
Add:Non operating Income -79.45%28.45K-0.84%931.93K-35.75%796.06K99.51%643.73K6.10%138.46K46.44%939.87K100.91%1.24M3.43%322.66K-36.80%130.5K-55.91%641.8K
Less:Non operating expense 3,209.69%389.84K-89.81%363.16K21.36%649.33K-64.68%175.19K-83.86%11.78K54.29%3.56M-74.70%535.05K-75.50%496.06K-59.41%72.97K-36.39%2.31M
Total profit -4.53%31.38M31.92%83.41M10.55%84.12M12.09%53.67M6.66%32.87M-36.52%63.23M-1.64%76.09M-24.73%47.88M-2.59%30.82M129.27%99.6M
Less:Income tax cost -34.24%6.26M68.40%25.15M-2.54%18.67M26.74%19.16M32.34%9.52M-52.79%14.93M-18.32%19.16M-22.81%15.12M-21.22%7.2M139.76%31.64M
Net profit 7.59%25.12M20.63%58.26M14.96%65.45M5.33%34.51M-1.16%23.35M-28.94%48.29M5.61%56.93M-25.59%32.76M4.97%23.62MFLtoP67.96M
Net profit from continuing operation 7.59%25.12M20.63%58.26M14.96%65.45M5.33%34.51M-1.16%23.35M-28.94%48.29M5.61%56.93M-25.59%32.76M4.97%23.62M--67.96M
Less:Minority Profit 367.98%1.18M595.39%1.26M-133.53%-498.72K-128.77%-227.1K-375.76%-439.74K84.70%-254.05K68.47%1.49M329.06%789.35K-77.45%159.47K86.47%-1.66M
Net profit of parent company owners 0.65%23.94M17.41%57M18.94%65.95M8.64%34.74M1.39%23.79M-30.27%48.55M4.57%55.45M-27.94%31.97M7.64%23.47M120.41%69.62M
Earning per share
Basic earning per share 0.00%0.0422.22%0.1120.00%0.120.00%0.060.00%0.04-30.77%0.090.00%0.1-25.00%0.060.00%0.04120.31%0.13
Diluted earning per share 0.00%0.0422.22%0.1120.00%0.120.00%0.060.00%0.04-30.77%0.090.00%0.1-25.00%0.060.00%0.04120.31%0.13
Other composite income -88.74%223.7K140.59%4.81M127.98%3.67M177.52%6.69M125.85%1.99M-198.47%-11.86M-672.58%-13.11M-38.43%-8.63M-29.88%-7.69M-343.13%-3.97M
Other composite income of parent company owners -88.74%223.7K140.59%4.81M127.98%3.67M177.52%6.69M125.85%1.99M-402.81%-11.86M-672.58%-13.11M-38.43%-8.63M-29.88%-7.69M-244.32%-2.36M
Other composite income of minority owners ---------------------------------------1.62M
Total composite income 0.03%25.35M73.12%63.07M57.74%69.12M70.70%41.2M59.00%25.34M-43.06%36.43M-22.02%43.82M-36.14%24.13M-3.92%15.94M118.19%63.99M
Total composite income of parent company owners -6.24%24.17M68.49%61.81M64.45%69.62M77.45%41.42M63.39%25.78M-45.46%36.69M-23.47%42.33M-38.79%23.34M-0.64%15.78M119.81%67.26M
Total composite income of minority owners 367.98%1.18M595.39%1.26M-133.53%-498.72K-128.77%-227.1K-375.76%-439.74K92.24%-254.05K68.47%1.49M329.06%789.35K-77.45%159.47K73.31%-3.28M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg